Meridian Bioscience Inc
VIVO
VIVO was delisted on the 30th of January, 2023.
215 hedge funds and large institutions have $1.08B invested in Meridian Bioscience Inc in 2021 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 69 increasing their positions, 75 reducing their positions, and 22 closing their positions.
114% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 22
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
47% more capital invested
Capital invested by funds: $732M → $1.08B (+$345M)
12% more funds holding
Funds holding: 192 → 215 (+23)
8% less repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 75
35% less call options, than puts
Call options by funds: $6.29M | Put options by funds: $9.63M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EARNEST Partners
Atlanta,
Georgia
|
+$103M |
| 2 |
New York State Common Retirement Fund
Albany,
New York
|
+$19.5M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.98M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
+$5.47M |
| 5 |
MGIM
M&G Investment Management
London,
United Kingdom
|
+$4.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$30.2M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$8.77M |
| 3 |
Renaissance Technologies
New York
|
-$8.65M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.89M |
| 5 |
State Street
Boston,
Massachusetts
|
-$6.73M |
VIVO Hedge Fund Activity: Q1 2021 in Review
215 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q1 2021, worth a combined $1.08B — up 47% from $732M a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new VIVO positions and 22 closed out — a net gain of 25 holders — while 69 added to existing stakes and 75 trimmed.
The largest buyer was EARNEST Partners, opening a new position worth an estimated $103M. The largest seller was Deerfield Management, cutting an estimated $30.2M.
- 215 institutional investors held Meridian Bioscience Inc (VIVO) as of Q1 2021, up from 192 in Q4 2020.
- Funds reported $1.08B of Meridian Bioscience Inc stock for Q1 2021, up 47% quarter-over-quarter.
- 47 funds opened new Meridian Bioscience Inc positions in Q1 2021 and 22 closed out, a net change of +25 holders.
- The largest Meridian Bioscience Inc buyer in Q1 2021 was EARNEST Partners, an estimated $103M added.
- The largest Meridian Bioscience Inc seller in Q1 2021 was Deerfield Management, an estimated $30.2M sold.
Based on aggregated 13F filings for Q1 2021.